Adicet Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
Received IND clearance and initiated first-in-human Phase 1 clinical trial for lead asset, ADI-001, an
Received IND clearance and initiated first-in-human Phase 1 clinical trial for lead asset, ADI-001, an